• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does Time of Day Impact Postpartum Hemorrhage Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Previous studies that assessed the relationship between time of day and postpartum hemorrhage (PPH) outcomes have focused on cesarean delivery and frequency of PPH rather than morbidity
  • Yee et al. (Obstetrics & Gynecology, 2018) examined whether postpartum hemorrhage is managed differently and had different outcomes during the day or night

METHODS: 

  • Secondary analysis of a multicenter observational obstetric cohort of mother–neonate pairs  
    • NICHD/ MFMU network study
  • Original study: Assessment of Perinatal Excellence 
    • 115,502 women and their neonates (deliveries between 2008 to 2011) 
  • For this present study
    • Inclusion criteria: Women had delivered singleton or twin births  
    • Postpartum hemorrhage defined as  
      • EBL >500 cc for vaginal delivery 
      • EBL >1,000 cc for cesarean delivery 
      • Treatment for PPH 
  • Nighttime delivery: Between 8 PM and 6 AM 
  • Primary outcome  
    • Composite of maternal morbidity 
      • Death | Hysterectomy | ICU admission | Transfusion | Unanticipated procedure for bleeding 
  • Secondary outcomes  
    • EBL | Uterotonic use | Procedures to treat postpartum bleeding

RESULTS: 

  • 7917 women with PPH  
    • 2,709 (34.2%) delivered at night 
    • Vaginal delivery: 5.3%  
    • Cesarean: 10.5%  
  • Women who delivered at night 
    • Were younger 
    • Had a lower body mass index 
    • Were more likely to have government-sponsored insurance 
    • Be nulliparous 
    • Have hypertension 
    • Use neuraxial analgesia 
    • Deliver vaginally 
  • After adjusting for potential confounders, there was no significant difference in primary composite outcome  
    • 15.5% night vs 17.5% day 
    • adjusted odds ratio (OR) 0.89 (95% CI, 0.77–1.03) 
  • Secondary outcome differences likewise did not show statistically significant differences in adjusted analyses

CONCLUSION: 

  • In this diverse cohort, after adjusting for variables, no significant association was identified between time of day of delivery and PPH morbidity or specific interventions  
  • Limitations include 
    • Change in PPH definition in 2017, after the Assessment of Perinatal Excellence study was completed  
    • Underpowered to assess maternal death or uncommon surgical interventions, including hysterectomy  
    • Sites were at academic centers and therefore may not be generalizable  
      • E.g. ‘float’ system for residents  
  • The authors state 

Such findings suggest women and their health care providers can be reassured that time of delivery does not appear to compromise care or outcomes for this obstetric emergency. 

Learn More – Primary Sources: 

Daytime Compared With Nighttime Differences in Management and Outcomes of Postpartum Hemorrhage


Now You Can Get Clinical Research Summaries Direct to Your Email/Text | Tap Here to Learn More

 

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Postpartum Hemorrhage – Medications to Treat Uterine Atony 
Does ART Increase Risk of Postpartum Hemorrhage?
How Effective is Intrauterine Balloon Tamponade for Severe Postpartum Hemorrhage

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site